{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:23:40Z","timestamp":1790346220501,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bbi.2024.04.011","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T11:28:48Z","timestamp":1712748528000},"page":"353-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders \u2013 An individual patient data meta-analysis"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4596-4287","authenticated-orcid":false,"given":"Mattia","family":"Campana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Yakimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Moussiopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Maurus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"L\u00f6hrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Raabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matin","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Benros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Meyer zu H\u00f6rste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloi","family":"Gin\u00e9-Serv\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Labad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Boix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenija","family":"Yeeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Meyer-Lotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Dobrowolny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Malchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Siafis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Halstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Siskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Strube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkomiet","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbi.2024.04.011_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187141","article-title":"Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period","volume":"12","author":"Abdin","year":"2017","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bbi.2024.04.011_b0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/138920009788498996","article-title":"Gender differences in p-glycoprotein expression and function: effects on drug disposition and outcome","volume":"10","author":"Bebawy","year":"2009","journal-title":"Curr Drug Metab"},{"issue":"4","key":"10.1016\/j.bbi.2024.04.011_b0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biopsych.2013.09.023","article-title":"The epidemiologic evidence linking autoimmune diseases and psychosis","volume":"75","author":"Benros","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2024.04.011_b0020","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1038\/nprot.2006.390","article-title":"Administration and interpretation of the Trail Making Test","volume":"1","author":"Bowie","year":"2006","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/schbul\/sbab105","article-title":"Cerebrospinal fluid pathologies in schizophrenia-spectrum disorder-a retrospective chart review","volume":"48","author":"Campana","year":"2022","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bbi.2024.04.011_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-023-01572-3","article-title":"Blood-brain barrier dysfunction and folate and vitamin B12 levels in first-episode schizophrenia-spectrum psychosis: a retrospective chart review","author":"Campana","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12987-020-0173-2","article-title":"Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient","volume":"17","author":"Castellazzi","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.bbi.2024.04.011_b0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/schbul\/sbaa145","article-title":"Predictors of treatment-resistant and clozapine-resistant schizophrenia: a 12-year follow-up study of first-episode schizophrenia-spectrum disorders","volume":"47","author":"Chan","year":"2021","journal-title":"Schizophr Bull"},{"issue":"2","key":"10.1016\/j.bbi.2024.04.011_b0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pscychresns.2010.05.002","article-title":"Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function","volume":"183","author":"de Klerk","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbi.2024.04.011_b0050","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fimmu.2019.00726","article-title":"The Cerebrospinal Fluid in Multiple Sclerosis","volume":"10","author":"Deisenhammer","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbi.2024.04.011_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2022.100989","article-title":"Sex differences in the blood-brain barrier: Implications for mental health","volume":"65","author":"Dion-Albert","year":"2022","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.bbi.2024.04.011_b0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainres.2014.08.011","article-title":"Adverse effects of antipsychotics on micro-vascular endothelial cells of the human blood-brain barrier","volume":"1583","author":"Elmorsy","year":"2014","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41398-020-00967-3","article-title":"Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis","volume":"10","author":"Endres","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2024.04.011_b0070","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/schbul\/sbt137","article-title":"Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification","volume":"39","author":"Farooq","year":"2013","journal-title":"Schizophr Bull"},{"issue":"2","key":"10.1016\/j.bbi.2024.04.011_b0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, ehavioural, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"issue":"4","key":"10.1016\/j.bbi.2024.04.011_b0080","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-023-01976-6","article-title":"The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis","volume":"28","author":"Gigase","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2024.04.011_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110424","article-title":"Routine cerebrospinal fluid parameters as biomarkers in first-episode psychosis: A prospective observational study","volume":"112","author":"Gine-Serven","year":"2022","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbi.2024.04.011_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.789179","article-title":"Gender differences in clinical and psychosocial features among persons with schizophrenia: a mini review","volume":"12","author":"Giordano","year":"2021","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0095","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1038\/s41467-022-33797-6","article-title":"Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia","volume":"13","author":"Gracias","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0100","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bbi.2024.04.011_b0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3182(95)71666-8","article-title":"Global assessment of functioning","volume":"36","author":"Hall","year":"1995","journal-title":"A Modified Scale. Psychosomatics"},{"issue":"4","key":"10.1016\/j.bbi.2024.04.011_b0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2024.04.011_b0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41380-021-01200-3","article-title":"Treatment resistance in psychiatry: state of the art and new directions","volume":"27","author":"Howes","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2024.04.011_b0125","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/schbul\/sbac098","article-title":"Cerebrospinal fluid and blood biomarkers of neuroinflammation and blood-brain barrier in psychotic disorders and individually matched healthy controls","volume":"48","author":"Jeppesen","year":"2022","journal-title":"Schizophr Bull"},{"issue":"2","key":"10.1016\/j.bbi.2024.04.011_b0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"9","key":"10.1016\/j.bbi.2024.04.011_b0135","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.bbi.2024.04.011_b0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.bbi.2024.04.011_b0145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2024.04.011_b0150","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"2 Suppl","key":"10.1016\/j.bbi.2024.04.011_b0155","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2215-0366(16)30375-3","article-title":"Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study","volume":"4","author":"Lennox","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.bbi.2024.04.011_b0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbi.2024.04.011_b0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12883-016-0564-9","article-title":"Albumin and multiple sclerosis","volume":"16","author":"LeVine","year":"2016","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.bbi.2024.04.011_b0175","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1192\/bjo.2023.22","article-title":"The relationship between blood-brain barrier dysfunction and neurocognitive impairments in first-episode psychosis: findings from a retrospective chart analysis","volume":"9","author":"Maurus","year":"2023","journal-title":"Bjpsych Open"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12987-020-00223-2","article-title":"Sex difference in cerebrospinal fluid\/blood albumin quotients in patients with schizophreniform and affective psychosis","volume":"17","author":"Meixensberger","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"8","key":"10.1016\/j.bbi.2024.04.011_b0185","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/pgs.11.55","article-title":"Relationship between P-glycoprotein and second-generation antipsychotics","volume":"12","author":"Moons","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.bbi.2024.04.011_b0190","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.bbi.2024.04.011_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/916198","article-title":"Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review","volume":"2012","author":"Ochoa","year":"2012","journal-title":"Schizophr Res Treatment"},{"issue":"5","key":"10.1016\/j.bbi.2024.04.011_b0200","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/acps.12944","article-title":"Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis","volume":"138","author":"Orhan","year":"2018","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"10.1016\/j.bbi.2024.04.011_b0205","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41380-018-0220-4","article-title":"Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis","volume":"24","author":"Orlovska-Waast","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s44220-022-00001-z","article-title":"Predicting treatment resistance from first-episode psychosis using routinely collected clinical information","volume":"1","author":"Osimo","year":"2023","journal-title":"Nat Ment Health"},{"issue":"5","key":"10.1016\/j.bbi.2024.04.011_b0215","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1192\/bjp.2018.24","article-title":"Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders","volume":"212","author":"Oviedo-Salcedo","year":"2018","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0220","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41398-021-01751-7","article-title":"Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables","volume":"11","author":"Oviedo-Salcedo","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bbi.2024.04.011_b0225","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.bbi.2024.04.011_b0230","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1111\/jcmm.13767","article-title":"Evidence for sex difference in the CSF\/plasma albumin ratio in \u223c20 000 patients and 335 healthy volunteers","volume":"22","author":"Parrado-Fernandez","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.59249\/OAMT2710","article-title":"The importance of cerebrospinal fluid investigation in first-episode psychosis","volume":"96","author":"Paval","year":"2023","journal-title":"Yale J Biol Med"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","article-title":"The blood-brain barrier in psychosis","volume":"5","author":"Pollak","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.04.011_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-019-0090-z","article-title":"The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research","volume":"6","author":"Potkin","year":"2020","journal-title":"NPJ Schizophr"},{"issue":"Pt B","key":"10.1016\/j.bbi.2024.04.011_b0250","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","article-title":"Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders","volume":"1628","author":"Qosa","year":"2015","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.bbi.2024.04.011_b0255","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.4088\/JCP.13m08853","article-title":"Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials","volume":"75","author":"Rabinowitz","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2024.04.011_b0260","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1038\/s41380-021-01244-5","article-title":"Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses","volume":"26","author":"Rauber","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2024.04.011_b0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.bbi.2024.04.011_b0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-02059-2","article-title":"Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis","author":"Romer","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2024.04.011_b0275","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.bbadis.2011.05.004","article-title":"Conserved aquaporin 4 levels associated with reduction of brain edema are mediated by estrogen in the ischemic brain after experimental stroke","volume":"1812","author":"Shin","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.bbi.2024.04.011_b0280","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00406-023-01569-y","article-title":"Cytokine alterations in CSF and serum samples of patients with a first episode of schizophrenia: results and methodological considerations","volume":"273","author":"Singh","year":"2023","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"11","key":"10.1016\/j.bbi.2024.04.011_b0285","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0706743717718167","article-title":"Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis","volume":"62","author":"Siskind","year":"2017","journal-title":"Can J Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2024.04.011_b0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.2021.61","article-title":"Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis","volume":"220","author":"Siskind","year":"2022","journal-title":"Br J Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2024.04.011_b0295","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.biopsych.2022.04.002","article-title":"Neuroinflammatory Biomarkers in Cerebrospinal Fluid From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects","volume":"92","author":"Sorensen","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbi.2024.04.011_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114997","article-title":"Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies","volume":"320","author":"Storosum","year":"2023","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbi.2024.04.011_b0305","first-page":"545","article-title":"Labormedizinische Spezialbefundung und \u00e4rztliche Verantwortung","volume":"18","author":"Trendelenburg","year":"1994","journal-title":"J Lab Med"},{"key":"10.1016\/j.bbi.2024.04.011_b0310","doi-asserted-by":"crossref","unstructured":"Tumani HH, A. Bachhuber, F. Chapter 2 \u2013 The cerebrospinal fluid and barriers \u2013 anatomic and physiologic considerations. In: Florian Deisenhammer CET, Hayrettin Tumani, (ed). Handbook of Clinical Neurology, vol. 1462018, pp 21-32.","DOI":"10.1016\/B978-0-12-804279-3.00002-2"},{"issue":"6","key":"10.1016\/j.bbi.2024.04.011_b0315","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11307-012-0556-0","article-title":"P-glycoprotein function at the blood-brain barrier: effects of age and gender","volume":"14","author":"van Assema","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.bbi.2024.04.011_b0320","doi-asserted-by":"crossref","unstructured":"Webb PB, C. Essential Epidemiology: An Introduction for Students and Health Professionals 2010.","DOI":"10.1017\/CBO9780511997303"},{"key":"10.1016\/j.bbi.2024.04.011_b0325","unstructured":"GA Wells BS, D O\u2019Connell, J Peterson, V Welch, M Losos, P Tugwell,. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute."},{"key":"10.1016\/j.bbi.2024.04.011_b0330","article-title":"Neurologische Labordiagnostik","author":"Wildemann","year":"2006","journal-title":"Georg Thieme Verlag"},{"issue":"9","key":"10.1016\/j.bbi.2024.04.011_b0335","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.euroneuro.2017.06.011","article-title":"How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis","volume":"27","author":"Zhu","year":"2017","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124003568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124003568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T20:37:49Z","timestamp":1729283869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124003568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":67,"alternative-id":["S0889159124003568"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.04.011","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders \u2013 An individual patient data meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}